UPDATE: Warfarin Genetic Testing Decreases Hospitalization Rate, Study Finds | GenomeWeb

This article has been updated to include comments from the ACC meeting.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing for variants related to warfarin treatment response decreased hospitalization rates by almost one third in a prospective study of patients at sites across the country, according to research being presented today at the American College of Cardiology's scientific session in Atlanta.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.